Cardiac Contractility Modulation Therapy for Heart Failure – First Romanian Experience

1 Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; Authors/Task Force Members; Document Reviewers. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. J. Heart Fail. 2016, 18, 891–975. PonikowskiP VoorsAA AnkerSD BuenoH ClelandJG CoatsAJ FalkV González-JuanateyJR HarjolaVP JankowskaEA JessupM LindeC NihoyannopoulosP ParissisJT PieskeB RileyJP RosanoGM RuilopeLM RuschitzkaF RuttenFH van der MeerP Authors/Task Force Members; Document Reviewers. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC Eur. J. Heart Fail. 2016 18 891 975 10.1002/ejhf.59227207191 Search in Google Scholar

2 Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002 Mar 21;346(12):877–883. MossAJ ZarebaW HallWJ KleinH WilberDJ CannomDS DaubertJP HigginsSL BrownMW AndrewsML Multicenter Automatic Defibrillator Implantation Trial II Investigators Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction N Engl J Med 2002 Mar 21 346 12 877 883 10.1056/NEJMoa01347411907286 Search in Google Scholar

3 Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225–237. BardyGH LeeKL MarkDB PooleJE PackerDL BoineauR DomanskiM TroutmanC AndersonJ JohnsonG McNultySE Clapp-ChanningN Davidson-RayLD FrauloES FishbeinDP LuceriRM IpJH Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med. 2005 352 3 225 237 10.1056/NEJMoa04339915659722 Search in Google Scholar

4 Díaz-Infante E, Mont L, Leal J, García-Bolao I, Fernández-Lozano I, Hernández-Madrid A, Pérez-Castellano N, Sitges M, Pavón-Jiménez R, Barba J, Cavero MA, Moya JL, Pérez-Isla L, Brugada J; SCARS Investigators. Predictors of lack of response to resynchronization therapy. Am J Cardiol 2005;95:1436–1440. Díaz-InfanteE MontL LealJ García-BolaoI Fernández-LozanoI Hernández-MadridA Pérez-CastellanoN SitgesM Pavón-JiménezR BarbaJ CaveroMA MoyaJL Pérez-IslaL BrugadaJ SCARS Investigators Predictors of lack of response to resynchronization therapy Am J Cardiol 2005 95 1436 1440 10.1016/j.amjcard.2005.02.00915950566 Search in Google Scholar

5 Lund LH, Jurga J, Edner M, Benson L, Dahlström U, Linde C, Alehagen U. Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction. Eur Heart J. 2013;34(7):529–539. LundLH JurgaJ EdnerM BensonL DahlströmU LindeC AlehagenU Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction Eur Heart J. 2013 34 7 529 539 10.1093/eurheartj/ehs30523041499 Search in Google Scholar

6 Butter C, Rastogi S, Minden HH, Meyhöfer J, Burkhoff D, Sabbah HN. Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure. J Am Coll Cardiol. 2008 May 6;51(18):1784–1789. ButterC RastogiS MindenHH MeyhöferJ BurkhoffD SabbahHN Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure J Am Coll Cardiol. 2008 May 6 51 18 1784 1789 10.1016/j.jacc.2008.01.03618452785 Search in Google Scholar

7 Gupta RC, Mishra S, Rastogi S, Wang M, Rousso B, Mika Y, Remppis A, Sabbah HN. Ca(2+)-binding proteins in dogs with heart failure: effects of cardiac contractility modulation electrical signals. Clin Transl Sci. 2009;2(3):211–215. GuptaRC MishraS RastogiS WangM RoussoB MikaY RemppisA SabbahHN Ca(2+)-binding proteins in dogs with heart failure: effects of cardiac contractility modulation electrical signals Clin Transl Sci. 2009 2 3 211 215 10.1111/j.1752-8062.2009.00097.x535073320443895 Search in Google Scholar

8 Lyon AR, Samara MA, Feldman DS. Cardiac contractility modulation therapy in advanced systolic heart failure. Nat Rev Cardiol. 2013;10(10):584–598. LyonAR SamaraMA FeldmanDS Cardiac contractility modulation therapy in advanced systolic heart failure Nat Rev Cardiol. 2013 10 10 584 598 10.1038/nrcardio.2013.11423939481 Search in Google Scholar

9 Tint D, Florea R, Micu S. New Generation Cardiac Contractility Modulation Device-Filling the Gap in Heart Failure Treatment. J Clin Med. 2019;8(5):588. TintD FloreaR MicuS New Generation Cardiac Contractility Modulation Device-Filling the Gap in Heart Failure Treatment J Clin Med 2019 8 5 588 10.3390/jcm8050588657216431035648 Search in Google Scholar

10 Stix G, Borggrefe M, Wolpert C, Hindricks G, Kottkamp H, Böcker D, Wichter T, Mika Y, Ben-Haim S, Burkhoff D, Wolzt M, Schmidinger H. Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure. Eur Heart J. 2004;25(8):650–655. StixG BorggrefeM WolpertC HindricksG KottkampH BöckerD WichterT MikaY Ben-HaimS BurkhoffD WolztM SchmidingerH Chronic electrical stimulation during the absolute refractory period of the myocardium improves severe heart failure Eur Heart J. 2004 25 8 650 655 10.1016/j.ehj.2004.02.02715084369 Search in Google Scholar

11 Borggrefe MM, Lawo T, Butter C, Schmidinger H, Lunati M, Pieske B, Misier AR, Curnis A, Böcker D, Remppis A, Kautzner J, Stühlinger M, Leclerq C, Táborsky M, Frigerio M, Parides M, Burkhoff D, Hindricks G. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. Eur Heart J. 2008;29(8):1019–1028. BorggrefeMM LawoT ButterC SchmidingerH LunatiM PieskeB MisierAR CurnisA BöckerD RemppisA KautznerJ StühlingerM LeclerqC TáborskyM FrigerioM ParidesM BurkhoffD HindricksG Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure Eur Heart J. 2008 29 8 1019 1028 10.1093/eurheartj/ehn02018270213 Search in Google Scholar

12 Kadish A, Nademanee K, Volosin K, Krueger S, Neelagaru S, Raval N, Obel O, Weiner S, Wish M, Carson P, Ellenbogen K, Bourge R, Parides M, Chiacchierini RP, Goldsmith R, Goldstein S, Mika Y, Burkhoff D, Abraham WT. A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. Am Heart J. 2011;161(2):329–337.e1–2. KadishA NademaneeK VolosinK KruegerS NeelagaruS RavalN ObelO WeinerS WishM CarsonP EllenbogenK BourgeR ParidesM ChiacchieriniRP GoldsmithR GoldsteinS MikaY BurkhoffD AbrahamWT A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure Am Heart J. 2011 161 2 329 337.e1–2 10.1016/j.ahj.2010.10.02521315216 Search in Google Scholar

13 Abraham WT, Lindenfeld J, Reddy VY, Hasenfuss G, Kuck KH, Boscardin J, Gibbons R, Burkhoff D; FIX-HF-5C Investigators and Coordinators. A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with moderately reduced left ventricular ejection fraction and a narrow QRS duration: study rationale and design. J Card Fail. 2015;21(1):16–23. AbrahamWT LindenfeldJ ReddyVY HasenfussG KuckKH BoscardinJ GibbonsR BurkhoffD FIX-HF-5C Investigators and Coordinators A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with moderately reduced left ventricular ejection fraction and a narrow QRS duration: study rationale and design J Card Fail. 2015 21 1 16 23 10.1016/j.cardfail.2014.09.011439099525285748 Search in Google Scholar

14 Abraham WT, Kuck KH, Goldsmith RL, Lindenfeld J, Reddy VY, Carson PE, Mann DL, Saville B, Parise H, Chan R, Wiegn P, Hastings JL, Kaplan AJ, Edelmann F, Luthje L, Kahwash R, Tomassoni GF, Gutterman DD, Stagg A, Burkhoff D, Hasenfuß G. A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation. JACC Heart Fail 2018;6:874–883. AbrahamWT KuckKH GoldsmithRL LindenfeldJ ReddyVY CarsonPE MannDL SavilleB PariseH ChanR WiegnP HastingsJL KaplanAJ EdelmannF LuthjeL KahwashR TomassoniGF GuttermanDD StaggA BurkhoffD HasenfußG A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation JACC Heart Fail 2018 6 874 883 10.1016/j.jchf.2018.04.01029754812 Search in Google Scholar

15 Borggrefe M, Burkhoff D. Clinical effects of cardiac contractility modulation (CCM) as a treatment for chronic heart failure. Eur J Heart Fail 2012;14:703–712. BorggrefeM BurkhoffD Clinical effects of cardiac contractility modulation (CCM) as a treatment for chronic heart failure Eur J Heart Fail 2012 14 703 712 10.1093/eurjhf/hfs07822696514 Search in Google Scholar

16 Liu, M.; Fang, F.; Luo, X.X.; Shlomo, B.-H.; Burkhoff, D.; Chan, J.Y.; Chan, C.-P.; Cheung, L.; Rousso, B.; Gutterman, D.; et al. Improvement of long-term survival by cardiac contractility modulation in heart failure patients: A case–control study. Int. J. Cardiol. 2016, 206, 122–126. LiuM. FangF. LuoX.X. ShlomoB.-H. BurkhoffD. ChanJ.Y. ChanC.-P. CheungL. RoussoB. GuttermanD. Improvement of long-term survival by cardiac contractility modulation in heart failure patients: A case–control study Int. J. Cardiol. 2016 206 122 126 10.1016/j.ijcard.2016.01.07126788686 Search in Google Scholar

17 Abraham WT, Nademanee K, Volosin K, Krueger S, Neelagaru S, Raval N, Obel O, Weiner S, Wish M, Carson P, Ellenbogen K, Bourge R, Parides M, Chiacchierini RP, Goldsmith R, Goldstein S, Mika Y, Burkhoff D, Kadish A; FIX-HF-5 Investigators and Coordinators. Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. J Card Fail. 2011;17(9):710–717. AbrahamWT NademaneeK VolosinK KruegerS NeelagaruS RavalN ObelO WeinerS WishM CarsonP EllenbogenK BourgeR ParidesM ChiacchieriniRP GoldsmithR GoldsteinS MikaY BurkhoffD KadishA FIX-HF-5 Investigators and Coordinators Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure J Card Fail. 2011 17 9 710 717 10.1016/j.cardfail.2011.05.00621872139 Search in Google Scholar

18 Anker SD, Borggrefe M, Neuser H, Ohlow MA, Röger S, Goette A, Remppis BA, Kuck KH, Najarian KB, Gutterman DD, Rousso B, Burkhoff D, Hasenfuss G. Cardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fraction. Eur J Heart Fail. 2019;21(9):1103–1113. AnkerSD BorggrefeM NeuserH OhlowMA RögerS GoetteA RemppisBA KuckKH NajarianKB GuttermanDD RoussoB BurkhoffD HasenfussG Cardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fraction Eur J Heart Fail. 2019 21 9 1103 1113 10.1002/ejhf.137430652394 Search in Google Scholar

19 Kuschyk J, Falk P, Demming T, Marx O, Morley D, Rao I, Burkhoff D. Long-term clinical experience with cardiac contractility modulation therapy delivered by the Optimizer Smart system. Eur J Heart Fail. 2021 May 17. doi: 10.1002/ejhf.2202. KuschykJ FalkP DemmingT MarxO MorleyD RaoI BurkhoffD Long-term clinical experience with cardiac contractility modulation therapy delivered by the Optimizer Smart system Eur J Heart Fail 2021 May 17 10.1002/ejhf.2202 836015934002440 Open DOISearch in Google Scholar

20 Nägele H, Behrens S, Eisermann C. Cardiac contractility modulation in non-responders to cardiac resynchronization therapy. Europace 2008, 10, 1375–1380. NägeleH BehrensS EisermannC Cardiac contractility modulation in non-responders to cardiac resynchronization therapy Europace 2008 10 1375 1380 10.1093/europace/eun25718776196 Search in Google Scholar

21 Kuschyk J, Nägele H, Heinz-Kuck K, Butter C, Lawo T, Wietholt D, Roeger S, Gutterman D, Burkhoff D, Rousso B, Borggrefe M. Cardiac contractility modulation treatment in patients with symptomatic heart failure despite optimal medical therapy and cardiac resynchronization therapy (CRT). Int. J. Cardiol. 2019;277:173–177. KuschykJ NägeleH Heinz-KuckK ButterC LawoT WietholtD RoegerS GuttermanD BurkhoffD RoussoB BorggrefeM Cardiac contractility modulation treatment in patients with symptomatic heart failure despite optimal medical therapy and cardiac resynchronization therapy (CRT) Int. J. Cardiol. 2019 277 173 177 10.1016/j.ijcard.2018.10.08630409733 Search in Google Scholar

22 Röger S, Schneider R, Rudic B, Liebe V, Stach K, Schimpf R, Borggrefe M, Kuschyk J. Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation. Europace. 2014;16(8):1205–1209. RögerS SchneiderR RudicB LiebeV StachK SchimpfR BorggrefeM KuschykJ Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation Europace. 2014 16 8 1205 1209 10.1093/europace/euu05024706089 Search in Google Scholar